173 related articles for article (PubMed ID: 38213814)
1. Gut microbiota alterations in acute myocardial infarction: (diabetic) context is everything.
Lymperopoulos A
Ann Transl Med; 2023 Dec; 11(12):404. PubMed ID: 38213814
[No Abstract] [Full Text] [Related]
2. Loss of Gut Microbiota Alters Immune System Composition and Cripples Postinfarction Cardiac Repair.
Tang TWH; Chen HC; Chen CY; Yen CYT; Lin CJ; Prajnamitra RP; Chen LL; Ruan SC; Lin JH; Lin PJ; Lu HH; Kuo CW; Chang CM; Hall AD; Vivas EI; Shui JW; Chen P; Hacker TA; Rey FE; Kamp TJ; Hsieh PCH
Circulation; 2019 Jan; 139(5):647-659. PubMed ID: 30586712
[TBL] [Abstract][Full Text] [Related]
3. Changes in gut microbiota, metabolite SCFAs, and GPR43 expression in obese diabetic mice after sleeve gastrectomy.
Guo Y; Liu C; Zhao X; Zhang X; Wu Q; Wang Z; Lu J
J Appl Microbiol; 2022 Aug; 133(2):555-568. PubMed ID: 35437874
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiome mediates the protective effects of exercise after myocardial infarction.
Zhou Q; Deng J; Pan X; Meng D; Zhu Y; Bai Y; Shi C; Duan Y; Wang T; Li X; Sluijter JP; Xiao J
Microbiome; 2022 May; 10(1):82. PubMed ID: 35637497
[TBL] [Abstract][Full Text] [Related]
5. Cyclocarya paliurus polysaccharides alleviate type 2 diabetic symptoms by modulating gut microbiota and short-chain fatty acids.
Yao Y; Yan L; Chen H; Wu N; Wang W; Wang D
Phytomedicine; 2020 Oct; 77():153268. PubMed ID: 32663709
[TBL] [Abstract][Full Text] [Related]
6. Alterations of gut microbiota-derived metabolites in gestational diabetes mellitus and clinical significance.
Gao Y; Chen H; Li J; Ren S; Yang Z; Zhou Y; Xuan R
J Clin Lab Anal; 2022 Apr; 36(4):e24333. PubMed ID: 35285096
[TBL] [Abstract][Full Text] [Related]
7. Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations.
van de Wouw M; Boehme M; Lyte JM; Wiley N; Strain C; O'Sullivan O; Clarke G; Stanton C; Dinan TG; Cryan JF
J Physiol; 2018 Oct; 596(20):4923-4944. PubMed ID: 30066368
[TBL] [Abstract][Full Text] [Related]
8. Microbiome-metabolome reveals that the Suxiao Jiuxin pill attenuates acute myocardial infarction associated with fatty acid metabolism.
Liao J; Zhang Y; Ma C; Wu G; Zhang W
J Ethnopharmacol; 2023 Aug; 312():116529. PubMed ID: 37086873
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota combined with metabolites reveals unique features of acute myocardial infarction patients different from stable coronary artery disease.
Dong C; Yang Y; Wang Y; Hu X; Wang Q; Gao F; Sun S; Liu Q; Li L; Liu J; Tang Y; Zhang S; Wu C; Zhu H
J Adv Res; 2023 Apr; 46():101-112. PubMed ID: 35750287
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of probiotics on the modulation of gut microbiota in the treatment of diabetic nephropathy.
Nagase N; Ikeda Y; Tsuji A; Kitagishi Y; Matsuda S
World J Diabetes; 2022 Mar; 13(3):150-160. PubMed ID: 35432750
[TBL] [Abstract][Full Text] [Related]
11. Compositional alterations of the gut microbiota in acute myocardial infarction patients with type 2 diabetes mellitus.
Lei C; Zhang X; Chen E; Lin L; Zhou Z; Wang Z; Liu T; Liu Z
Ann Transl Med; 2023 Jun; 11(9):317. PubMed ID: 37405000
[TBL] [Abstract][Full Text] [Related]
12. Association of gut microbiota with sort-chain fatty acids and inflammatory cytokines in diabetic patients with cognitive impairment: A cross-sectional, non-controlled study.
Du Y; Li X; An Y; Song Y; Lu Y
Front Nutr; 2022; 9():930626. PubMed ID: 35938126
[TBL] [Abstract][Full Text] [Related]
13. Featured article: Structure moderation of gut microbiota in liraglutide-treated diabetic male rats.
Zhang Q; Xiao X; Zheng J; Li M; Yu M; Ping F; Wang T; Wang X
Exp Biol Med (Maywood); 2018 Jan; 243(1):34-44. PubMed ID: 29171288
[TBL] [Abstract][Full Text] [Related]
14. Dysbiosis of Gut Microbiota in Patients With Acute Myocardial Infarction.
Han Y; Gong Z; Sun G; Xu J; Qi C; Sun W; Jiang H; Cao P; Ju H
Front Microbiol; 2021; 12():680101. PubMed ID: 34295318
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol improves diabetic kidney disease by modulating the gut microbiota-short chain fatty acids axis in
Yan H; Zhang Y; Lin X; Huang J; Zhang F; Chen C; Ren H; Zheng S; Yang J; Hui S
Int J Food Sci Nutr; 2024 May; 75(3):264-276. PubMed ID: 38238900
[TBL] [Abstract][Full Text] [Related]
16. Dynamic modulation of gut microbiota improves post-myocardial infarct tissue repair in rats via butyric acid-mediated histone deacetylase inhibition.
Song T; Guan X; Wang X; Qu S; Zhang S; Hui W; Men L; Chen X
FASEB J; 2021 Mar; 35(3):e21385. PubMed ID: 33565193
[TBL] [Abstract][Full Text] [Related]
17. Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus.
Wu J; Yang K; Fan H; Wei M; Xiong Q
Front Endocrinol (Lausanne); 2023; 14():1114424. PubMed ID: 37229456
[TBL] [Abstract][Full Text] [Related]
18. Dapagliflozin modulates the faecal microbiota after myocardial infarction in non-diabetic mice.
Li Z; Wang K; Ding Y; Ma W; Sun Y; Liu X; Qian L; Li Y; Hong J; Xu D
Clin Exp Pharmacol Physiol; 2023 Jan; 50(1):68-81. PubMed ID: 36164968
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiota and diabetic kidney diseases: Pathogenesis and therapeutic perspectives.
Lin JR; Wang ZT; Sun JJ; Yang YY; Li XX; Wang XR; Shi Y; Zhu YY; Wang RT; Wang MN; Xie FY; Wei P; Liao ZH
World J Diabetes; 2022 Apr; 13(4):308-318. PubMed ID: 35582668
[TBL] [Abstract][Full Text] [Related]
20. Sodium butyrate ameliorates diabetic retinopathy in mice via the regulation of gut microbiota and related short-chain fatty acids.
Huang Y; Wang Z; Ye B; Ma JH; Ji S; Sheng W; Ye S; Ou Y; Peng Y; Yang X; Chen J; Tang S
J Transl Med; 2023 Jul; 21(1):451. PubMed ID: 37420234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
